AIMC Topic: Vaccines, Inactivated

Clear Filters Showing 1 to 6 of 6 articles

A prospective cohort-based artificial intelligence evaluation system for the protective efficacy and immune response of SARS-CoV-2 inactivated vaccines.

International immunopharmacology May 10, 2024
BACKGROUND: Novel coronaviruses constitute a significant health threat, prompting the adoption of vaccination as the primary preventive measure. However, current evaluations of immune response and vaccine efficacy are deemed inadequate.
Humans Immunity, Cellular COVID-19 Vaccines Antibodies, Viral Male Middle Aged Female SARS-CoV-2 Young Adult Adult Aged Vaccines, Inactivated Immunity, Humoral COVID-19 Prospective Studies Immunization, Secondary Vaccine Efficacy Artificial Intelligence Machine Learning Antibodies, Neutralizing
View on PubMed DOI

Artificial Intelligence Applied to Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children.

Frontiers in immunology Oct 5, 2020
The number of patients affected by chronic diseases with special vaccination needs is burgeoning. In this scenario, predictive markers of immunogenicity, as well as signatures of immune responses are typically missing even though it would especially ...
Coinfection Influenza, Human Influenza Vaccines Computational Biology Vaccination Vaccines, Inactivated Hemagglutination Inhibition Tests Influenza A Virus, H1N1 Subtype Immunogenicity, Vaccine Reproducibility of Results Gene Expression Profiling HIV Infections Child Transcriptome Artificial Intelligence Prognosis Humans
View on PubMed DOI

Immunogenicity of Concentrated and Purified Inactivated Avian Influenza Vaccine Formulation.

Archives of Razi Institute Dec 1, 2018
Avian influenza (AI) H9N2 is a low pathogenic virus subtype belonging to Orthomyxoviridae family. Given the prevalence of this subtype as an infectious agent in poultry industry, special attention has been always directed toward the development of va...
Vaccines, Inactivated Immunogenicity, Vaccine Poultry Diseases Influenza Vaccines Animals Influenza A Virus, H9N2 Subtype Influenza in Birds Chickens
View on PubMed DOI

An inactivated influenza D virus vaccine partially protects cattle from respiratory disease caused by homologous challenge.

Veterinary microbiology Dec 21, 2016
Originally isolated from swine, the proposed influenza D virus has since been shown to be common in cattle. Inoculation of IDV to naïve calves resulted in mild respiratory disease histologically characterized by tracheitis. As several studies have as...
Thogotovirus Virus Shedding Cattle Cattle Diseases Antibodies, Viral Viral Vaccines Viral Load Antigens, Viral Animals Vaccination Bovine Respiratory Disease Complex Vaccines, Inactivated Orthomyxoviridae Infections
View on PubMed DOI

Reappraisal of the Immunogenicity and Safety of Three Hepatitis A Vaccines in Adolescents.

Journal of Korean medical science Dec 24, 2015
Although the overall incidence of hepatitis A in Korea has been decreasing, adolescents remain highly vulnerable to its outbreaks. This study was conducted to compare the immunogenicity and safety of three hepatitis A vaccines in Korean adolescents. ...
Hepatitis A Antibodies Adolescent Hepatitis A Antibody Formation Humans Young Adult Female Vaccines, Inactivated Hepatitis A Vaccines Republic of Korea Male
View on PubMed DOI

Establishment of hepatitis A vaccine (inactivated, non-adsorbed) BRP batches 2 and 3.

Pharmeuropa bio & scientific notes Jan 1, 2015
The current hepatitis A vaccine (HAV), inactivated, non-adsorbed, European Pharmacopoeia (Ph. Eur.) Biological Reference Preparation (BRP) is used for the in vitro potency assay of HAV as prescribed by the Ph. Eur. general chapter 2.7.14 Assay of hep...
Calibration Vaccines, Inactivated Chemistry, Pharmaceutical Hepatitis A Vaccines Reference Standards Europe World Health Organization
View on PubMed
Popular Topics
Recent Journals